Sigma Of Australia, Aspen Of South Africa Agree To $799 Million Sale
This article was originally published in PharmAsia News
Executive Summary
Australia's Sigma Pharmaceuticals and South Africa's Aspen Pharmacare Holdings have agreed to Aspen buying all of Sigma's drug business for $799 million